Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Phylagen

Explore full profile

Microbiome analytics for supply chain origin verification.

San Francisco, United StatesFounded 2014Biotech & Life Sciences
Valuation $50–100M Last recorded · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Phylagen and the history behind them.

About Phylagen

Phylagen is a data analytics company that provides supply chain transparency and indoor air quality monitoring through microbial forensics. Founded in 2014 by Dr. Jessica Green and Dr. Harrison Dillon, the San Francisco-based firm leverages the unique environmental microbiome—the invisible ecosystem of microorganisms present everywhere—to create verifiable data for businesses. Dr. Green is an internationally recognized scientist in microbiome science and technology, while Dr. Dillon is a biotechnology entrepreneur who previously co-founded Solazyme.

The company's core technology platform analyzes the DNA of microbes found in dust and on surfaces to create a unique "microbial fingerprint" for a specific geographical location, such as a factory or farm. By collecting samples from products, Phylagen can verify their point of origin by matching their microbial signature to its extensive database. This service, its first commercial product, allows brands and retailers in industries like apparel and agriculture to ensure their goods were produced in authorized facilities, helping to combat unauthorized subcontracting and support ethical sourcing. The process involves clients or partners collecting dust samples which are then sent to Phylagen for sequencing and analysis, with algorithms identifying the most informative genetic material for traceability.

Initially focused on supply chain forensics, Phylagen expanded its services, particularly in response to the COVID-19 pandemic, to include indoor air and environmental safety. Its "Ecology by Phylagen™" service is an enterprise-level airborne virus monitoring system that detects the presence of pathogens, including SARS-CoV-2, from settled air samples. This offering provides businesses with a tool to monitor the health and safety of indoor spaces like offices and manufacturing facilities, identifying the presence of viruses shed by inhabitants, even if they are asymptomatic. This service is active in numerous countries and has been deployed by clients such as Silverstein Properties across 15 million square feet of office space, including the World Trade Center.

In February 2019, Phylagen secured $14 million in a Series A funding round. The round was led by Cultivian Sandbox, Breakout Ventures, and Working Capital, with participation from investors including AgFunder, 3M Ventures, and the Dolby Family Ventures. The company utilizes a B2B business model, providing its analytics as a service to large enterprises seeking to mitigate supply chain risks and ensure workplace safety.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
San Francisco, United States
Employees
8
Open positions
None listed
Dealroom signal
62.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Supply Chain Management, Analytics, Biotechnology, Genetics and genomics, Synthetic Biology, Spinout
Technology
Artificial Intelligence, Big Data, Deep Tech, Machine Learning
Business model
Manufacturing
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Feb 2019 $14M $56M Western Technology Investment · AgFunder · Breakout Ventures · Dolby Family Ventures ↗
SUPPORT PROGRAM✓Other financing Sep 2017 $5.1M — DARPA ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Phylagen website traffic

Latest recorded traffic for Phylagen is 330 monthly website visits, up 371.4% over the last three months. Phylagen's team grew 0% over the past year.

Latest monthly visits330 3-month web change+371.4% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Breakout Ventures
  • Cultivian Sandbox Ventures
  • Working Capital
  • Western Technology Investment
  • AgFunder
  • Dolby Family Ventures
  • 3M Ventures
  • Blackhorn Ventures

Other known investors7 additional known investors

  • DARPA
  • University of Oregon
  • J Ventures
  • J-Ventures
  • Nadav Aharony
  • Oded Hermoni
  • Technology Pioneers | World Economic Forum
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Phylagen on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Phylagen’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.